These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38626313)

  • 1. Disrupted BMP-9 Signaling Impairs Pulmonary Vascular Integrity in Hepatopulmonary Syndrome.
    Robert F; Certain MC; Baron A; Thuillet R; Duhaut L; Ottaviani M; Chelgham MK; Normand C; Berrebeh N; Ricard N; Furlan V; Desroches-Castan A; Gonzales E; Jacquemin E; Sitbon O; Humbert M; Bailly S; Coilly A; Guignabert C; Tu L; Savale L
    Am J Respir Crit Care Med; 2024 Sep; 210(5):648-661. PubMed ID: 38626313
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.
    Lejealle C; Paradis V; Bruno O; de Raucourt E; Francoz C; Soubrane O; Lebrec D; Bedossa P; Valla D; Mal H; Vilgrain V; Durand F; Rautou PE
    Chest; 2019 Jan; 155(1):123-136. PubMed ID: 30292761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced circulating BMP10 and BMP9 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis.
    Owen NE; Alexander GJ; Sen S; Bunclark K; Polwarth G; Pepke-Zaba J; Davenport AP; Morrell NW; Upton PD
    EBioMedicine; 2020 Jun; 56():102794. PubMed ID: 32454407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod.
    Baweja S; Kumari A; Negi P; Tomar A; Tripathi DM; Mourya AK; Rastogi A; Subudhi PD; Thangariyal S; Kumar G; Kumar J; Reddy GS; Sood AK; Vashistha C; Sarohi V; Bihari C; Maiwall R; Sarin SK
    J Hepatol; 2023 Jul; 79(1):167-180. PubMed ID: 36996943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: a potential mechanism in experimental hepatopulmonary syndrome.
    Luo B; Liu L; Tang L; Zhang J; Stockard CR; Grizzle WE; Fallon MB
    J Hepatol; 2003 May; 38(5):556-63. PubMed ID: 12713865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1-Endoglin-Smad1/5/9 signalling.
    Yang C; Sun M; Yang Y; Han Y; Wu X; Wu X; Cao H; Chen L; Lei Y; Hu X; Chen Y; Zeng Z; Li J; Shu X; Yang Z; Lu K; Li Y; Wang X; Yi B
    Eur J Clin Invest; 2024 Aug; 54(8):e14212. PubMed ID: 38591651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
    Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
    J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
    Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
    Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ET-1 and TNF-alpha in HPS: analysis in prehepatic portal hypertension and biliary and nonbiliary cirrhosis in rats.
    Luo B; Liu L; Tang L; Zhang J; Ling Y; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G294-303. PubMed ID: 14715521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension.
    Hira HS; Kumar J; Tyagi SK; Jain SK
    Indian J Chest Dis Allied Sci; 2003; 45(3):165-71. PubMed ID: 12866633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatopulmonary syndrome.
    Koch DG; Fallon MB
    Clin Liver Dis; 2014 May; 18(2):407-20. PubMed ID: 24679503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
    Liu C; Gao J; Chen B; Chen L; Belguise K; Yu W; Lu K; Wang X; Yi B
    Biochem Pharmacol; 2017 Aug; 138():205-215. PubMed ID: 28642034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
    Zhu J; Qiu J; Chen K; Wang W; Zheng S
    Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common bile duct ligation in the rat: a model of intrapulmonary vasodilatation and hepatopulmonary syndrome.
    Fallon MB; Abrams GA; McGrath JW; Hou Z; Luo B
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G779-84. PubMed ID: 9142908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatopulmonary syndrome: update on pathogenesis and clinical features.
    Zhang J; Fallon MB
    Nat Rev Gastroenterol Hepatol; 2012 Sep; 9(9):539-49. PubMed ID: 22751459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates.
    Mendizabal M; Goldberg DS; Piñero F; Arufe DT; José de la Fuente M; Testa P; Coronel M; Baratta S; Podestá LG; Fallon MB; Silva MO
    Ann Hepatol; 2017; 16(4):548-554. PubMed ID: 28611257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
    Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
    Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
    Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spleen derived monocytes regulate pulmonary vascular permeability in Hepatopulmonary syndrome through the OSM-FGF/FGFR1 signaling.
    Li L; Li J; Li W; Ma Y; Li S
    Transl Res; 2024 Sep; 271():93-104. PubMed ID: 38797433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension.
    Møller S; Krag A; Madsen JL; Henriksen JH; Bendtsen F
    Liver Int; 2009 Nov; 29(10):1528-37. PubMed ID: 19725890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.